FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and represents a pharmaceutical combination for treating in pain conditions in the form of a solid dosage form for oral administration, characterised by the fact that it contains Mirtazapine 5 mg - 50 mg; Tizanidine 0.5 - 6 mg in ratio 20:1-5:1, and a pharmaceutically acceptable carrier.
EFFECT: invention provides creating an effective agent for preventing or treating a pain condition well-tolerated by patients.
6 cl, 2 ex
